Forum Discussion

YLY's avatar
YLY
Member
9 years ago

Aromatase Inhibitor (AI) vs Tamoxifen for premenopausal women

Hi all, I've been diagnosed with invasive ductal carcinoma, stage 1a, grade 2, ER and PR positive, HER2 negative, nodes all clear. Age 35.  As I also found out that i am BRCA2 positive, I will als...
BRCA1-BRCA2
dcis
hormone-therapy
lumpectomy
young-women
NaomiV's avatar
NaomiV
Member
9 years ago
I am 36 - and at high risk for DVT (have already had 2 blood clots while on chemo) and so have been recommended Aromatase Inhibitors rather than Tamoxifen.
My oncologist advised me that one of the most important differences is that the bone density loss is much more rapid with Aromatase Inhibitors than Tamoxifen in premenopausal women - so it's something we would need to actively manage. Something to consider being so young!